ReP USP - Resultado da busca

Artigo de periodico
Hyper-inflammation and complement in COVID-19 (2023)
Silva, Bruno Garcia Peixoto Pires da; Calado, Rodrigo Tocantins
Source: American Journal of Hematology. Unidade: FMRP
Subjects: COVID-19, ATIVAÇÃO DE COMPLEMENTO, INFLAMAÇÃO, NEUTRÓFILOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Bruno Garcia Peixoto Pires da e CALADO, Rodrigo Tocantins. Hyper-inflammation and complement in COVID-19. American Journal of Hematology, v. 98, p. S74-S81, 2023Tradução . . Disponível em: https://doi.org/10.1002/ajh.26746. Acesso em: 11 nov. 2024.
APA
Silva, B. G. P. P. da, & Calado, R. T. (2023). Hyper-inflammation and complement in COVID-19. American Journal of Hematology, 98, S74-S81. doi:10.1002/ajh.26746
NLM
Silva BGPP da, Calado RT. Hyper-inflammation and complement in COVID-19 [Internet]. American Journal of Hematology. 2023 ; 98 S74-S81.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/ajh.26746
Vancouver
Silva BGPP da, Calado RT. Hyper-inflammation and complement in COVID-19 [Internet]. American Journal of Hematology. 2023 ; 98 S74-S81.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/ajh.26746
Trabalho de evento-resumo periodico
Triphenylphosphonium-desferrioxamine as a candidate mitochondrial iron chelator (2017)
Alta, Roxana Yesenia Pastrana; Machini, Maria Teresa ; Espósito, Breno Pannia ; Vitorino, Hector Aguilar; Wisnovsky, Simon; Kelley, Shana
Source: American Journal of Hematology. Conference titles: Congress of the International BioIron Society (IBIS). Unidade: IQ
Subjects: MITOCÔNDRIAS, FERRO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALTA, Roxana Yesenia Pastrana et al. Triphenylphosphonium-desferrioxamine as a candidate mitochondrial iron chelator. American Journal of Hematology. Hoboken: Instituto de Química, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 2017
APA
Alta, R. Y. P., Machini, M. T., Espósito, B. P., Vitorino, H. A., Wisnovsky, S., & Kelley, S. (2017). Triphenylphosphonium-desferrioxamine as a candidate mitochondrial iron chelator. American Journal of Hematology. Hoboken: Instituto de Química, Universidade de São Paulo.
NLM
Alta RYP, Machini MT, Espósito BP, Vitorino HA, Wisnovsky S, Kelley S. Triphenylphosphonium-desferrioxamine as a candidate mitochondrial iron chelator. American Journal of Hematology. 2017 ; 92( 8):[citado 2024 nov. 11 ]
Vancouver
Alta RYP, Machini MT, Espósito BP, Vitorino HA, Wisnovsky S, Kelley S. Triphenylphosphonium-desferrioxamine as a candidate mitochondrial iron chelator. American Journal of Hematology. 2017 ; 92( 8):[citado 2024 nov. 11 ]
Artigo de periodico
Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma (2016)
Panero, Julieta; Alves-Paiva, Raquel M.; Roisman, Alejandro; Santana-Lemos, Bárbara Amélia Aparecida; Falcão, Roberto Passetto; Oliveira, Gustavo; Martins, Diego; Stanganelli, Carmen; Slavutsky, Irma; Calado, Rodrigo Tocantins
Source: American Journal of Hematology. Unidade: FMRP
Subjects: LINFOMA, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PANERO, Julieta et al. Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma. American Journal of Hematology, v. 91, n. 5, p. 481-485, 2016Tradução . . Disponível em: https://doi.org/10.1002/ajh.24324. Acesso em: 11 nov. 2024.
APA
Panero, J., Alves-Paiva, R. M., Roisman, A., Santana-Lemos, B. A. A., Falcão, R. P., Oliveira, G., et al. (2016). Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma. American Journal of Hematology, 91( 5), 481-485. doi:10.1002/ajh.24324
NLM
Panero J, Alves-Paiva RM, Roisman A, Santana-Lemos BAA, Falcão RP, Oliveira G, Martins D, Stanganelli C, Slavutsky I, Calado RT. Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma [Internet]. American Journal of Hematology. 2016 ; 91( 5): 481-485.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/ajh.24324
Vancouver
Panero J, Alves-Paiva RM, Roisman A, Santana-Lemos BAA, Falcão RP, Oliveira G, Martins D, Stanganelli C, Slavutsky I, Calado RT. Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma [Internet]. American Journal of Hematology. 2016 ; 91( 5): 481-485.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/ajh.24324
Artigo de periodico
Myelodysplastic syndromes in South America: A multinational study of 1080 patients (2015)
Belli, Carolina B.; Pinheiro, Ronald Feitosa; Bestach, Yesica; Larripa, Irene B.; Tanizawa, Roberta Sandra da Silva; Alfonso, Graciela; Gonzalez, Jacqueline; Rosenhain, Mariana; Watman, Nora; Silva, Marcela Cavalcante de Andrade; Aranguren, Pedro Negri; Rivello, Hernán García; Magalhaes, Silvia M. M.; Valladares, Ximena; Undurraga, María S.; Velloso, Elvira R. P.
Source: American Journal of Hematology. Unidade: FM
Subjects: PROGNÓSTICO, DOENÇAS DA MEDULA ÓSSEA, NEOPLASIAS POR TIPO HISTOLÓGICO, LEUCEMIA MIELOIDE AGUDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BELLI, Carolina B. et al. Myelodysplastic syndromes in South America: A multinational study of 1080 patients. American Journal of Hematology, v. 90, n. 10, p. 851-858, 2015Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/ajh.24097/epdf. Acesso em: 11 nov. 2024.
APA
Belli, C. B., Pinheiro, R. F., Bestach, Y., Larripa, I. B., Tanizawa, R. S. da S., Alfonso, G., et al. (2015). Myelodysplastic syndromes in South America: A multinational study of 1080 patients. American Journal of Hematology, 90( 10), 851-858. doi:10.1002/ajh.24097
NLM
Belli CB, Pinheiro RF, Bestach Y, Larripa IB, Tanizawa RS da S, Alfonso G, Gonzalez J, Rosenhain M, Watman N, Silva MC de A, Aranguren PN, Rivello HG, Magalhaes SMM, Valladares X, Undurraga MS, Velloso ERP. Myelodysplastic syndromes in South America: A multinational study of 1080 patients [Internet]. American Journal of Hematology. 2015 ; 90( 10): 851-858.[citado 2024 nov. 11 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/ajh.24097/epdf
Vancouver
Belli CB, Pinheiro RF, Bestach Y, Larripa IB, Tanizawa RS da S, Alfonso G, Gonzalez J, Rosenhain M, Watman N, Silva MC de A, Aranguren PN, Rivello HG, Magalhaes SMM, Valladares X, Undurraga MS, Velloso ERP. Myelodysplastic syndromes in South America: A multinational study of 1080 patients [Internet]. American Journal of Hematology. 2015 ; 90( 10): 851-858.[citado 2024 nov. 11 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/ajh.24097/epdf
Artigo de periodico
Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma (2012)
Maiolino, Angelo; Hungria, Vania T. M.; Garnica, Marcia; Duarte, Gislaine Oliveira; Oliveira, Luciana Corrêa Oliveira de; Mercante, Daniel R.; Miranda, Eliana C.; Quero, Adriana A.; Peres, Ana L. M.; Barros, José C.; Tanaka, Paola; Magalhães, Roberto P.; Rego, Eduardo Magalhães; Lorand-Metze, Irene; Lima, Carmen S. P.; Renault, Ilana Z.; Braggio, Esteban; Chiattone, Carlos; Nucci, Márcio; Souza, Carmino A. de
Source: American Journal of Hematology. Unidade: FMRP
Subjects: ANTINEOPLÁSICOS, TERAPIA COMBINADA, MIELOMA MÚLTIPLO, MODELOS DE RISCOS PROPORCIONAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAIOLINO, Angelo et al. Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma. American Journal of Hematology, v. 87, n. 10, p. 948-952, 2012Tradução . . Disponível em: https://doi.org/10.1002/ajh.23274. Acesso em: 11 nov. 2024.
APA
Maiolino, A., Hungria, V. T. M., Garnica, M., Duarte, G. O., Oliveira, L. C. O. de, Mercante, D. R., et al. (2012). Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma. American Journal of Hematology, 87( 10), 948-952. doi:10.1002/ajh.23274
NLM
Maiolino A, Hungria VTM, Garnica M, Duarte GO, Oliveira LCO de, Mercante DR, Miranda EC, Quero AA, Peres ALM, Barros JC, Tanaka P, Magalhães RP, Rego EM, Lorand-Metze I, Lima CSP, Renault IZ, Braggio E, Chiattone C, Nucci M, Souza CA de. Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma [Internet]. American Journal of Hematology. 2012 ; 87( 10): 948-952.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/ajh.23274
Vancouver
Maiolino A, Hungria VTM, Garnica M, Duarte GO, Oliveira LCO de, Mercante DR, Miranda EC, Quero AA, Peres ALM, Barros JC, Tanaka P, Magalhães RP, Rego EM, Lorand-Metze I, Lima CSP, Renault IZ, Braggio E, Chiattone C, Nucci M, Souza CA de. Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma [Internet]. American Journal of Hematology. 2012 ; 87( 10): 948-952.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/ajh.23274
Artigo de periodico-carta/editorial
New polymorphism in the NCF-2 gene leading to alternative splicing without altering gene expression or the respiratory burst activity [Carta] (2008)
Gómez, Lina Andrea; Rugeles, Maria Teresa; Patiño, Pablo Javier; Condino-Neto, Antonio
Source: American Journal of Hematology. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GÓMEZ, Lina Andrea et al. New polymorphism in the NCF-2 gene leading to alternative splicing without altering gene expression or the respiratory burst activity [Carta]. American Journal of Hematology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 2008
APA
Gómez, L. A., Rugeles, M. T., Patiño, P. J., & Condino-Neto, A. (2008). New polymorphism in the NCF-2 gene leading to alternative splicing without altering gene expression or the respiratory burst activity [Carta]. American Journal of Hematology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Gómez LA, Rugeles MT, Patiño PJ, Condino-Neto A. New polymorphism in the NCF-2 gene leading to alternative splicing without altering gene expression or the respiratory burst activity [Carta]. American Journal of Hematology. 2008 ; 83( 2): 172.[citado 2024 nov. 11 ]
Vancouver
Gómez LA, Rugeles MT, Patiño PJ, Condino-Neto A. New polymorphism in the NCF-2 gene leading to alternative splicing without altering gene expression or the respiratory burst activity [Carta]. American Journal of Hematology. 2008 ; 83( 2): 172.[citado 2024 nov. 11 ]
Artigo de periodico
Up-regulation of NADPH oxidase components and increased production of interferon-gamma by leukocytes from sickle cell disease patients (2008)
Marçal, Lívia E.; Dias-da-Motta, Péricles M.; Rehder, Jussara; Mamoni, Ronei L.; Blotta, Maria Helena S. L.; Whitney, Constance B.; Newburger, Peter E.; Costa, Fernando F.; Saad, Sara T. O.; Condino-Neto, Antonio
Source: American Journal of Hematology. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARÇAL, Lívia E. et al. Up-regulation of NADPH oxidase components and increased production of interferon-gamma by leukocytes from sickle cell disease patients. American Journal of Hematology, v. 83, n. 1, p. 41-45, 2008Tradução . . Disponível em: https://doi.org/10.1002/ajh.20991. Acesso em: 11 nov. 2024.
APA
Marçal, L. E., Dias-da-Motta, P. M., Rehder, J., Mamoni, R. L., Blotta, M. H. S. L., Whitney, C. B., et al. (2008). Up-regulation of NADPH oxidase components and increased production of interferon-gamma by leukocytes from sickle cell disease patients. American Journal of Hematology, 83( 1), 41-45. doi:10.1002/ajh.20991
NLM
Marçal LE, Dias-da-Motta PM, Rehder J, Mamoni RL, Blotta MHSL, Whitney CB, Newburger PE, Costa FF, Saad STO, Condino-Neto A. Up-regulation of NADPH oxidase components and increased production of interferon-gamma by leukocytes from sickle cell disease patients [Internet]. American Journal of Hematology. 2008 ; 83( 1): 41-45.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/ajh.20991
Vancouver
Marçal LE, Dias-da-Motta PM, Rehder J, Mamoni RL, Blotta MHSL, Whitney CB, Newburger PE, Costa FF, Saad STO, Condino-Neto A. Up-regulation of NADPH oxidase components and increased production of interferon-gamma by leukocytes from sickle cell disease patients [Internet]. American Journal of Hematology. 2008 ; 83( 1): 41-45.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/ajh.20991
Artigo de periodico-carta/editorial
A single nucleotide polymorphism in the promoter region of the NCF-2 gene (2007)
Gómez, Lina Andrea; Patiño, Pablo Javier; Novaira, Horacio Javier; Morales, Marcelo Marcos; Condino Neto, Antonio
Source: American Journal of Hematology. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GÓMEZ, Lina Andrea et al. A single nucleotide polymorphism in the promoter region of the NCF-2 gene. American Journal of Hematology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 2007
APA
Gómez, L. A., Patiño, P. J., Novaira, H. J., Morales, M. M., & Condino Neto, A. (2007). A single nucleotide polymorphism in the promoter region of the NCF-2 gene. American Journal of Hematology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Gómez LA, Patiño PJ, Novaira HJ, Morales MM, Condino Neto A. A single nucleotide polymorphism in the promoter region of the NCF-2 gene. American Journal of Hematology. 2007 ; 82( 12): 1124-1125.[citado 2024 nov. 11 ]
Vancouver
Gómez LA, Patiño PJ, Novaira HJ, Morales MM, Condino Neto A. A single nucleotide polymorphism in the promoter region of the NCF-2 gene. American Journal of Hematology. 2007 ; 82( 12): 1124-1125.[citado 2024 nov. 11 ]
Artigo de periodico
Plasma kinetics of a cholesterol-rich microemulsion in subjects with heterozygous beta-thalassemia (2004)
Naoum, Flávio Augusto; Gualandro, Sandra Fátima Menosi; Latrilha, Maria da Conceição M.; Maranhão, Raul Cavalcante
Source: American Journal of Hematology. Unidades: FCF, FM
Subjects: EMULSÕES (FORMAS FARMACÊUTICAS), LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAOUM, Flávio Augusto et al. Plasma kinetics of a cholesterol-rich microemulsion in subjects with heterozygous beta-thalassemia. American Journal of Hematology, v. 77, n. 4, p. 340-345, 2004Tradução . . Disponível em: https://doi.org/10.1002/ajh.20206. Acesso em: 11 nov. 2024.
APA
Naoum, F. A., Gualandro, S. F. M., Latrilha, M. da C. M., & Maranhão, R. C. (2004). Plasma kinetics of a cholesterol-rich microemulsion in subjects with heterozygous beta-thalassemia. American Journal of Hematology, 77( 4), 340-345. doi:10.1002/ajh.20206
NLM
Naoum FA, Gualandro SFM, Latrilha M da CM, Maranhão RC. Plasma kinetics of a cholesterol-rich microemulsion in subjects with heterozygous beta-thalassemia [Internet]. American Journal of Hematology. 2004 ; 77( 4): 340-345.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/ajh.20206
Vancouver
Naoum FA, Gualandro SFM, Latrilha M da CM, Maranhão RC. Plasma kinetics of a cholesterol-rich microemulsion in subjects with heterozygous beta-thalassemia [Internet]. American Journal of Hematology. 2004 ; 77( 4): 340-345.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/ajh.20206
Artigo de periodico
Atypical 'beta POT.S' haplotypes are generated by diverse genetic mechanisms (2000)
Zago, Marco Antônio; Silva Junior, W. A.; Dalle, B; Gualandro, Sandra Fátima Menosi; Hutz, M H; Lapoumeroulie, C; Tavella, M H; Araújo, A G; Krieger, José Eduardo; Elion, J; Krishnamoorthy, R
Source: American Journal of Hematology. Unidades: FMRP, FM
Assunto: DOENÇAS HEMATOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAGO, Marco Antônio et al. Atypical 'beta POT.S' haplotypes are generated by diverse genetic mechanisms. American Journal of Hematology, v. 63, p. 79-84, 2000Tradução . . Acesso em: 11 nov. 2024.
APA
Zago, M. A., Silva Junior, W. A., Dalle, B., Gualandro, S. F. M., Hutz, M. H., Lapoumeroulie, C., et al. (2000). Atypical 'beta POT.S' haplotypes are generated by diverse genetic mechanisms. American Journal of Hematology, 63, 79-84.
NLM
Zago MA, Silva Junior WA, Dalle B, Gualandro SFM, Hutz MH, Lapoumeroulie C, Tavella MH, Araújo AG, Krieger JE, Elion J, Krishnamoorthy R. Atypical 'beta POT.S' haplotypes are generated by diverse genetic mechanisms. American Journal of Hematology. 2000 ; 63 79-84.[citado 2024 nov. 11 ]
Vancouver
Zago MA, Silva Junior WA, Dalle B, Gualandro SFM, Hutz MH, Lapoumeroulie C, Tavella MH, Araújo AG, Krieger JE, Elion J, Krishnamoorthy R. Atypical 'beta POT.S' haplotypes are generated by diverse genetic mechanisms. American Journal of Hematology. 2000 ; 63 79-84.[citado 2024 nov. 11 ]
Artigo de periodico
Dose-dependent pulmonary syndrome in patients with thalassemia major receiving intravenous deferoxamine (1998)
Rego, Eduardo Magalhães; Boturão Neto, Edmir; Simões, Belinda Pinto; Zago, Marco Antonio
Source: American Journal of Hematology. Unidade: FMRP
Assunto: HEMATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REGO, Eduardo Magalhães et al. Dose-dependent pulmonary syndrome in patients with thalassemia major receiving intravenous deferoxamine. American Journal of Hematology, v. 58, p. 340-341, 1998Tradução . . Disponível em: https://doi.org/10.1002/(sici)1096-8652(199808)58:4%3C340::aid-ajh18%3E3.3.co;2-c. Acesso em: 11 nov. 2024.
APA
Rego, E. M., Boturão Neto, E., Simões, B. P., & Zago, M. A. (1998). Dose-dependent pulmonary syndrome in patients with thalassemia major receiving intravenous deferoxamine. American Journal of Hematology, 58, 340-341. doi:10.1002/(sici)1096-8652(199808)58:4%3C340::aid-ajh18%3E3.3.co;2-c
NLM
Rego EM, Boturão Neto E, Simões BP, Zago MA. Dose-dependent pulmonary syndrome in patients with thalassemia major receiving intravenous deferoxamine [Internet]. American Journal of Hematology. 1998 ; 58 340-341.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/(sici)1096-8652(199808)58:4%3C340::aid-ajh18%3E3.3.co;2-c
Vancouver
Rego EM, Boturão Neto E, Simões BP, Zago MA. Dose-dependent pulmonary syndrome in patients with thalassemia major receiving intravenous deferoxamine [Internet]. American Journal of Hematology. 1998 ; 58 340-341.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/(sici)1096-8652(199808)58:4%3C340::aid-ajh18%3E3.3.co;2-c
Artigo de periodico
Pulmonary leukostasis without hyperleukocytosis: a clinic-pathologic study of 16 cases (1992)
Soares, Fernando Augusto; Landell, G A M; Cardoso, M C M
Source: American Journal of Hematology. Unidade: FMRP
Assunto: HEMATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Fernando Augusto e LANDELL, G A M e CARDOSO, M C M. Pulmonary leukostasis without hyperleukocytosis: a clinic-pathologic study of 16 cases. American Journal of Hematology, v. 40, n. 1 , p. 28-32, 1992Tradução . . Disponível em: https://doi.org/10.1002/ajh.2830400106. Acesso em: 11 nov. 2024.
APA
Soares, F. A., Landell, G. A. M., & Cardoso, M. C. M. (1992). Pulmonary leukostasis without hyperleukocytosis: a clinic-pathologic study of 16 cases. American Journal of Hematology, 40( 1 ), 28-32. doi:10.1002/ajh.2830400106
NLM
Soares FA, Landell GAM, Cardoso MCM. Pulmonary leukostasis without hyperleukocytosis: a clinic-pathologic study of 16 cases [Internet]. American Journal of Hematology. 1992 ;40( 1 ): 28-32.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/ajh.2830400106
Vancouver
Soares FA, Landell GAM, Cardoso MCM. Pulmonary leukostasis without hyperleukocytosis: a clinic-pathologic study of 16 cases [Internet]. American Journal of Hematology. 1992 ;40( 1 ): 28-32.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/ajh.2830400106
Artigo de periodico
Chlorpromazine - induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis (1988)
Canoso, R T; Oliveira, R M
Source: American Journal of Hematology. Unidade: FM
Assunto: HEMATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CANOSO, R T e OLIVEIRA, R M. Chlorpromazine - induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis. American Journal of Hematology, v. 27, n. 4 , p. 272-5, 1988Tradução . . Disponível em: https://doi.org/10.1002/ajh.2830270408. Acesso em: 11 nov. 2024.
APA
Canoso, R. T., & Oliveira, R. M. (1988). Chlorpromazine - induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis. American Journal of Hematology, 27( 4 ), 272-5. doi:10.1002/ajh.2830270408
NLM
Canoso RT, Oliveira RM. Chlorpromazine - induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis [Internet]. American Journal of Hematology. 1988 ;27( 4 ): 272-5.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/ajh.2830270408
Vancouver
Canoso RT, Oliveira RM. Chlorpromazine - induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis [Internet]. American Journal of Hematology. 1988 ;27( 4 ): 272-5.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1002/ajh.2830270408

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Indexado em

Non normalized affiliation